loading

Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-27 2025-06-28 2025-03-29 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
9.83%
12,215.00
11,122.00 10,855.00 10,364.00 11,395.00
Operating Expenses
8.48%
9,960.00
9,181.00 9,021.00 8,648.00 9,379.00
Benefits Costs and Expenses
8.24%
10,062.00
9,296.00 9,146.00 8,744.00 9,454.00
Costs And Expenses
8.47%
9,960.00
9,182.00 9,021.00 8,648.00 9,379.00
Operating Income/Loss
16.18%
2,255.00
1,941.00 1,834.00 1,716.00 2,016.00
Income/Loss Before Equity Method Investments
17.91%
2,153.00
1,826.00 1,709.00 1,620.00 1,941.00
Income/Loss From Equity Method Investments
1,700%
-32.00
2.00 2.00 -14.00 33.00
Income/Loss From Continuing Operations Before Tax
17.91%
2,153.00
1,826.00 1,709.00 1,620.00 1,941.00
Income Tax Expense/Benefit, Deferred
170.08%
89.00
-127.00 - - -
Income Tax Expense/Benefit
26.09%
153.00
207.00 92.00 95.00 150.00
Income/Loss From Continuing Operations After Tax
23.53%
2,000.00
1,619.00 1,617.00 1,525.00 1,791.00
Net Income/Loss
21.53%
1,970.00
1,621.00 1,618.00 1,511.00 1,824.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
20.00%
6.00
5.00 2.00 4.00 -6.00
Basic Average Shares
100.26%
-1.00
378.00 378.00 378.00 -
Diluted Average Shares
100.00%
-
378.00 378.00 379.00 -
Basic Earnings Per Share
21.96%
5.22
4.28 4.28 3.99 4.79
Diluted Earnings Per Share
22.01%
5.21
4.27 4.28 3.98 4.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research DHR
$188.12
price up icon 1.00%
$571.68
price up icon 0.61%
diagnostics_research A
$111.50
price down icon 0.09%
diagnostics_research WAT
$284.93
price up icon 0.57%
diagnostics_research IQV
$165.19
price up icon 1.39%
Kapitalisierung:     |  Volumen (24h):